None
Quote | Dbv Techs Boulogne Bill (OTCMKTS:DBVTF)
Last: | $2.80 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $2.80 |
High: | $0 |
Low: | $0 |
Volume: | 24 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Dbv Techs Boulogne Bill (OTCMKTS:DBVTF)
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused...
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 through 3 years old) and children (4 through 7 years old) Strengthened exec...
Message Board Posts | Dbv Techs Boulogne Bill (OTCMKTS:DBVTF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Dbv Techs Boulogne Bill Company Name:
DBVTF Stock Symbol:
OTCMKTS Market:
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused...
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 through 3 years old) and children (4 through 7 years old) Strengthened exec...
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on trea...